financetom
Business
financetom
/
Business
/
American Exceptionalism Acquisition Corp. A Announces Pricing of Upsized $300,000,000 Initial Public Offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
American Exceptionalism Acquisition Corp. A Announces Pricing of Upsized $300,000,000 Initial Public Offering
Sep 25, 2025 3:22 PM

MENLO PARK, Calif., Sept. 25, 2025 /PRNewswire/ -- American Exceptionalism Acquisition Corp. A ( AEXA ) (the "Company") announced today that it has priced its upsized initial public offering of 30,000,000 Class A ordinary shares at $10.00 per share. The Class A ordinary shares will be listed on the New York Stock Exchange ("NYSE") and trade under the ticker symbol "AEXA" beginning September 26, 2025.

The Company is led by Chamath Palihapitiya, the founder and Managing Partner of Social Capital, and is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company intends to focus on businesses operating in the energy production, artificial intelligence, decentralized finance and defense industries.

Santander is acting as sole book-running manager. The Company has granted the underwriters a 45-day option to purchase up to an additional 4,500,000 Class A ordinary shares at the initial public offering price to cover over-allotments, if any.

The offering is being made only by means of a prospectus. When available, copies of the prospectus may be obtained for free from the U.S. Securities and Exchange Commission (the "SEC") website http://www.sec.gov; or from Santander US Capital Markets LLC, Attention: Santander US Capital Markets LLC, 437 Madison Avenue, New York, NY 10012, by email at [email protected], or by telephone at 833-818-1602. 

The registration statement relating to the securities became effective on September 25, 2025. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Forward-Looking Statements

This press release contains statements that constitute "forward-looking statements," including with respect to the proposed initial public offering and the anticipated use of the net proceeds. No assurance can be given that the offering discussed above will be completed on the terms described, or at all, or that the net proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's preliminary prospectus for the Company's offering filed with the SEC. Copies of these documents are available on the SEC's website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Media Contacts:

American Exceptionalism Acquisition Corp. A ( AEXA )

[email protected] 

View original content:https://www.prnewswire.com/news-releases/american-exceptionalism-acquisition-corp-a-announces-pricing-of-upsized-300-000-000-initial-public-offering-302567699.html

SOURCE American Exceptionalism Acquisition Corp. A ( AEXA )

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
U.S. FDA approves Supernus' drug-device combination for Parkinson's disease
U.S. FDA approves Supernus' drug-device combination for Parkinson's disease
Feb 4, 2025
Feb 4 (Reuters) - The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' ( SUPN ) drug-device combination to treat movement-related symptoms of Parkinson's disease, the drugmaker said on Tuesday. ...
Nomura Sees Higher Likelihood of U.S. Tariffs on Canada, Mexico Despite 30-Day Pause
Nomura Sees Higher Likelihood of U.S. Tariffs on Canada, Mexico Despite 30-Day Pause
Feb 4, 2025
09:13 AM EST, 02/04/2025 (MT Newswires) -- United States President Donald Trump over the weekend announced broad tariffs on Canada, Mexico, and China effective Tuesday, but implementation on Canada and Mexico Monday was postponed by one month, noted Nomura. The increase in China tariffs alone makes this the biggest single tariff increase Trump has enacted in either of his presidential...
Air Products names former Linde executive Eduardo Menezes as CEO
Air Products names former Linde executive Eduardo Menezes as CEO
Feb 4, 2025
Feb 4 (Reuters) - Industrial gases manufacturer Air Products said on Tuesday it has named former Linde executive Eduardo Menezes as its CEO and will succeed Seifi Ghasemi effective Feb. 7, amid pressure from activist investors. Last month, Air Products lost the proxy fight against Mantle Ridge after shareholders handed victory to the activist investor which had been pushing the...
Market Chatter: BP Delays Plans for Renewable Energy Plant in Australia
Market Chatter: BP Delays Plans for Renewable Energy Plant in Australia
Feb 4, 2025
09:15 AM EST, 02/04/2025 (MT Newswires) -- BP (BP) is delaying plans to convert its former Kwinana oil refinery in Australia to produce renewable fuels, Bloomberg reported Tuesday, citing an email from the company. The report also cited an internal memo that said BP has stopped or paused 30 projects since June as the oil and gas giant enacts cutbacks....
Copyright 2023-2026 - www.financetom.com All Rights Reserved